Arthur Elliot Hirshorn alias Dr. Root Cause Peptide
Website · renewingfunction.com
Practice location
56 Pointe
Circle Greenville, SC 29615
Funnel-first framing that runs on persuasion, light on published evidence.
Welcome to New Life Health, where Elliott Hirshorn and his team of 'functional medicine specialists' are ready to 'uncover the root cause' of your chronic misery with their secret 'advanced lab testing' and 'cutting-edge' peptide therapies! Forget your insurance and your real doctor; just swipe your HSA card for their exclusive TRT and nutraceutical stacks, because why pay for standard care when you can pay double for unproven 'functional' magic? They're the only ones who can 'restore function' and 'balance hormones'—because obviously, your regular doctor just 'covers up symptoms' with medication!
High grift signals
Score breakdown
Direct answer
Often searched as Dr Arthur Elliot Hirshorn. Dr. Trust Me Bro analyzed Dr. Arthur Elliot Hirshorn's claim that "Testosterone and hormone replacement therapy (HRT/TRT)" using transcript and metadata cross-checked against academic sources. Peer-reviewed literature indicates the claim is mixed in the medical literature: High-quality evidence supports testosterone replacement therapy (TRT) and hormone replacement therapy (HRT) for men who have clinically confirmed hypogonadism (low testosterone plus characteristic symptoms), not for general wellness in otherwise eugonadal men. Multiple randomized trials and meta-analyses show that TRT can improve sexual desire, erectile function, and sexual satisfaction in hypogonadal men, with modest benefits in quality of life and fatigue in some subgroups.[20][16] Major professional guidelines (Endocrine Society, American Urological Association, International Society for the Study of the Aging Male) endorse TRT for symptomatic men with consistently low morning testosterone and after exclusion of reversible causes, with dosing aimed at the mid-normal physiological range and close monitoring of hematocrit, prostate parameters, and cardiovascular risk.[18][15][6][21] Large contemporary RCTs and pooled analyses indicate that, in appropriately selected men with low testosterone, short- to medium-term TRT does not increase major adverse cardiovascular events, while improving anemia, bone density, and some metabolic parameters, though follow-up is still limited for long-term outcomes.[14][22][11] Overall, the evidence base supports TRT/HRT as a legitimate, guideline-backed therapy for male hypogonadism when used with clear indications, informed consent, and structured monitoring. Evidence contradicts broad influencer-style claims that testosterone or HRT/TRT are safe, universally beneficial, or appropriate for anti-aging or optimization in men without clear hypogonadism. Systematic reviews and RCTs show that benefits outside sexual function (energy, vitality, cognition, general well-being) are modest or inconsistent, and do not justify routine TRT in men with borderline or age-related declines alone.[12][19][16] Major guidelines explicitly recommend against starting TRT in men seeking to maintain fertility, and highlight that exogenous testosterone suppresses the hypothalamic–pituitary–testicular axis and can cause infertility.[13][21][18] Safety data show that TRT increases hematocrit and can lead to erythrocytosis, raising thrombotic risk; it can worsen untreated sleep apnea and heart failure, and requires regular monitoring for prostate-related issues, including PSA rise, even though current data do not show a clear increase in de novo prostate cancer.[13][8][22] There remain uncertainties and conflicting signals about long-term cardiovascular safety, arrhythmia risk, and other endpoints, and no high-quality evidence supports life-long supraphysiologic or non-indication-based testosterone use as some influencers imply.[8][11] Guidelines and reviews also emphasize that a substantial proportion of men are prescribed TRT without appropriate diagnostic workup or clear indication, which is considered misuse rather than evidence-based practice.[3][2][7] The mainstream medical position is that testosterone and hormone replacement therapy are evidence-based treatments for men with true hypogonadism—defined by consistent low morning testosterone levels plus compatible signs and symptoms—when alternative causes have been excluded and when therapy is delivered within physiological ranges under specialist or guideline-informed care.[18][15][6][21] TRT is not recommended as a general anti-aging, performance-enhancing, or wellness therapy in men with normal or age-appropriate testosterone, because benefits in those populations are small or absent and potential risks and monitoring burdens outweigh uncertain gains.[12][19] Professional societies advise shared decision-making, counseling about potential benefits (mainly sexual function, anemia, bone health) and known risks (erythrocytosis, sleep apnea worsening, fertility suppression, PSA increases, possible cardiovascular and arrhythmic concerns), and structured follow-up with laboratory and clinical monitoring at 3–6 months and annually thereafter.[18][15][22] Overall, mainstream practice accepts TRT/HRT as appropriate and beneficial for carefully selected hypogonadal men, but rejects casual or influencer-promoted use without proper diagnosis, risk stratification, and long-term safety oversight. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
Key findings
- False Authority: The practice claims 'functional medicine' can identify the 'root cause' of chronic conditions, a term often used to imply a diagnostic capability that standard medical boards do not grant to non-MD/DO functional practitioners, especially when paired with unproven therapies like…see section ↓
- Claim "Testosterone and hormone replacement therapy (HRT/TRT)": mixed in the medical literature.see section ↓
- Claim "Laser vaginal rejuvenation": mixed in the medical literature.see section ↓
- NPI registry confirms ARTHUR ELLIOT HIRSHORN as Unverified 'Dr.' title (likely non-MD/DO based on functional medicine scope) in South Carolina (NPI 1174867386).see section ↓
- Dr. Arthur Elliot Hirshorn shows credential inflation relative to stated vs likely credentials.see section ↓
- Against South Carolina Board of Chiropractic Examiners scope rules (S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)-(2)), these advertised activities appear outside Dr. Arthur Elliot Hirshorn's license (including conditions they merely list as ones they treat): Testosterone and hormone…see section ↓
- 19 of 19 advertised activities fall outside permitted Chiropractor scope in SC.see section ↓
- Claim "Peptides and nutraceuticals for weight loss": mixed in the medical literature.see section ↓
Claims & evidence
13 advertised conditions or treatments fall outside their license scope. Each box leads with state-board scope notation; literature cross-check follows when we matched a specific claim. Every card carries its receipts: the quoted wording, a live source link, and an archived copy.
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Testosterone and hormone replacement therapy (HRT/TRT).
Testosterone and hormone replacement therapy (HRT/TRT)
- Supports
- High-quality evidence supports testosterone replacement therapy (TRT) and hormone replacement therapy (HRT) for men who have clinically confirmed hypogonadism (low testosterone plus characteristic symptoms), not for general wellness in otherwise eugonadal men. Multiple randomized trials and meta-analyses show that TRT can improve sexual desire, erectile function, and sexual satisfaction in hypogonadal men, with modest benefits in quality of life and fatigue in some subgroups.[20][16] Major professional guidelines (Endocrine Society, American Urological Association, International Society for the Study of the Aging Male) endorse TRT for symptomatic men with consistently low morning testosterone and after exclusion of reversible causes, with dosing aimed at the mid-normal physiological range and close monitoring of hematocrit, prostate parameters, and cardiovascular risk.[18][15][6][21] Large contemporary RCTs and pooled analyses indicate that, in appropriately selected men with low testosterone, short- to medium-term TRT does not increase major adverse cardiovascular events, while improving anemia, bone density, and some metabolic parameters, though follow-up is still limited for long-term outcomes.[14][22][11] Overall, the evidence base supports TRT/HRT as a legitimate, guideline-backed therapy for male hypogonadism when used with clear indications, informed consent, and structured monitoring.
- Contradicts
- Evidence contradicts broad influencer-style claims that testosterone or HRT/TRT are safe, universally beneficial, or appropriate for anti-aging or optimization in men without clear hypogonadism. Systematic reviews and RCTs show that benefits outside sexual function (energy, vitality, cognition, general well-being) are modest or inconsistent, and do not justify routine TRT in men with borderline or age-related declines alone.[12][19][16] Major guidelines explicitly recommend against starting TRT in men seeking to maintain fertility, and highlight that exogenous testosterone suppresses the hypothalamic–pituitary–testicular axis and can cause infertility.[13][21][18] Safety data show that TRT increases hematocrit and can lead to erythrocytosis, raising thrombotic risk; it can worsen untreated sleep apnea and heart failure, and requires regular monitoring for prostate-related issues, including PSA rise, even though current data do not show a clear increase in de novo prostate cancer.[13][8][22] There remain uncertainties and conflicting signals about long-term cardiovascular safety, arrhythmia risk, and other endpoints, and no high-quality evidence supports life-long supraphysiologic or non-indication-based testosterone use as some influencers imply.[8][11] Guidelines and reviews also emphasize that a substantial proportion of men are prescribed TRT without appropriate diagnostic workup or clear indication, which is considered misuse rather than evidence-based practice.[3][2][7]
- Mainstream view
- The mainstream medical position is that testosterone and hormone replacement therapy are evidence-based treatments for men with true hypogonadism—defined by consistent low morning testosterone levels plus compatible signs and symptoms—when alternative causes have been excluded and when therapy is delivered within physiological ranges under specialist or guideline-informed care.[18][15][6][21] TRT is not recommended as a general anti-aging, performance-enhancing, or wellness therapy in men with normal or age-appropriate testosterone, because benefits in those populations are small or absent and potential risks and monitoring burdens outweigh uncertain gains.[12][19] Professional societies advise shared decision-making, counseling about potential benefits (mainly sexual function, anemia, bone health) and known risks (erythrocytosis, sleep apnea worsening, fertility suppression, PSA increases, possible cardiovascular and arrhythmic concerns), and structured follow-up with laboratory and clinical monitoring at 3–6 months and annually thereafter.[18][15][22] Overall, mainstream practice accepts TRT/HRT as appropriate and beneficial for carefully selected hypogonadal men, but rejects casual or influencer-promoted use without proper diagnosis, risk stratification, and long-term safety oversight. Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“testosterone and hormone replacement therapy (HRT/TRT)”
Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)-(2)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Psoriasis Treatment.
Psoriasis Treatment
No specific health claims of theirs were cross-checked against the literature.
“Psoriasis Treatment”
Rule: S.C. Code § 40-9-10(a)-(c); S.C. Code Regs. § 25-5(1)-(2)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Autoimmune Disease.
Autoimmune Disease
No specific health claims of theirs were cross-checked against the literature.
“Autoimmune Disease”
Rule: S.C. Code § 40-9-10(a)-(b); S.C. Code Regs. § 25-5(1)-(2)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Chronic Fatigue.
Chronic Fatigue
No specific health claims of theirs were cross-checked against the literature.
“Chronic Fatigue”
Rule: S.C. Code § 40-9-10(a)-(c); S.C. Code Regs. § 25-5(2)(c)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure IBS & Gastrointestinal Issues.
IBS & Gastrointestinal Issues
No specific health claims of theirs were cross-checked against the literature.
“IBS & Gastrointestinal Issues”
Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)-(2)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Infertility.
Infertility
No specific health claims of theirs were cross-checked against the literature.
“Infertility”
Rule: S.C. Code § 40-9-10(a)-(b); S.C. Code Regs. § 25-5
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Thyroid Disease.
Thyroid Disease
No specific health claims of theirs were cross-checked against the literature.
“Thyroid Disease”
Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)-(2)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Hormone Replacement Therapy (HRT).
Hormone Replacement Therapy (HRT)
No specific health claims of theirs were cross-checked against the literature.
“Hormone Replacement Therapy (HRT)”
Rule: S.C. Code § 40-9-10(b)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Testosterone Replacement Therapy (TRT).
Testosterone Replacement Therapy (TRT)
No specific health claims of theirs were cross-checked against the literature.
“Testosterone Replacement Therapy (TRT)”
Rule: S.C. Code § 40-9-10(b)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to advertise Prescribing testosterone replacement therapy (TRT) and peptide therapy for weight loss, which are medical treatments typically restricted to MD/DO physicians. as within their scope of practice.
Prescribing testosterone replacement therapy (TRT) and peptide therapy for weight loss, which are medical treatments typically restricted to MD/DO physicians.
No specific health claims of theirs were cross-checked against the literature.
“Testosterone Replacement Therapy (TRT)”
Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to diagnose, treat, or cure Laser vaginal rejuvenation.
Laser vaginal rejuvenation
- Supports
- The systematic review and meta-analysis of vaginal laser treatment for genitourinary syndrome of menopause (GSM) in breast cancer survivors reports that laser therapy improves subjective GSM symptoms and vaginal health scores, with studies generally showing statistically significant short‑term benefits on measures such as the Vaginal Health Index and symptom scales. [9][10][11][12] Another systematic review and meta-analysis comparing CO2 vaginal laser with vaginal estrogen found that laser produced similar improvements in GSM symptoms to estrogen therapy across six randomized clinical trials, suggesting laser may be a potential option for women who cannot or will not use estrogen. Narrative and systematic reviews in breast cancer survivors similarly describe consistent short‑term improvement in vulvovaginal atrophy/GSM symptoms and sexual function after laser treatments, lasting up to about 12 months, although based on small heterogeneous studies. Overall, high‑quality evidence supports that vaginal laser can provide short‑term relief of GSM/vulvovaginal atrophy symptoms in selected populations, especially where estrogen is contraindicated or not desired, but this is symptom treatment rather than proven structural “rejuvenation. ”
- Contradicts
- The main gaps and contradictions center on the marketing concept of “vaginal rejuvenation” (tightening, cosmetic enhancement, broad sexual improvement) rather than the more specific indication of GSM. Major position statements and guidelines on GSM and energy‑based devices conclude there are insufficient placebo‑controlled and sham‑controlled trials to establish long‑term efficacy and safety of vaginal laser, and therefore routine use for GSM or cosmetic vaginal rejuvenation cannot be recommended. [9][10][11][12] Regulatory communications have warned that the safety and effectiveness of energy‑based vaginal devices for vaginal laxity, sexual function, and cosmetic rejuvenation have not been established and that adverse events such as burns, scarring, dyspareunia, and chronic pain can occur. Health technology and policy reviews classify laser treatment for vulvovaginal atrophy and “vaginal rejuvenation” as investigational, citing limited high‑quality evidence, lack of long‑term outcome data, and uncertain complication rates. Where randomized sham‑controlled trials exist for related indications such as stress urinary incontinence, some have found no superiority of laser over sham, suggesting that broader claims of functional tightening or incontinence benefit are not reliably supported. Taken together, the evidence is relatively supportive for short‑term GSM symptom relief but weak or absent for claims of durable anatomical rejuvenation, vaginal tightening, enhanced sexual performance, or broad pelvic floor benefits, and long‑term safety data remain limited.
- Mainstream view
- The mainstream medical position is that vaginal laser therapy may be considered an emerging, potentially useful option for short‑term relief of GSM/vulvovaginal atrophy in carefully selected women, particularly those (such as breast cancer survivors) who cannot or prefer not to use vaginal estrogen, but that it remains investigational, with uncertain long‑term efficacy and safety. [9][10][11][12] Major menopause and sexual‑health societies state that energy‑based devices, including vaginal lasers, require robust long‑term, sham‑controlled trials before routine use can be recommended and that current evidence does not justify marketing them as established treatments for vaginal rejuvenation, tightening, or sexual enhancement. Regulatory agencies and clinical policy reviews reinforce that these devices are not approved for cosmetic “vaginal rejuvenation” indications and warn about possible harms, so mainstream guidance is cautious: use, if at all, should be within research settings or after thorough counseling about the limited evidence and potential risks.
“laser vaginal rejuvenation for comfort and function”
Rule: S.C. Code § 40-9-10(b); S.C.
Dr. Arthur Elliot Hirshorn is not licensed or approved by South Carolina Board of Chiropractic Examiners to advertise Peptides and nutraceuticals for weight loss as within their scope of practice.
Peptides and nutraceuticals for weight loss
- Supports
- The strongest support for the claim is for peptide-based prescription drugs, especially GLP-1/GIP agents used for obesity treatment. [18][19] Recent reviews and clinical literature describe semaglutide, liraglutide, and tirzepatide as effective peptide therapies for weight loss, with randomized trials and guideline-based practice showing clinically meaningful reductions in body weight when used in appropriate patients. [13][14][15][16] By contrast, for nutraceuticals there is some evidence of small average weight loss in adults with overweight or obesity, but the effect is generally modest and heterogeneous. [17] A comparative review found nutraceutical supplementation can produce a small weight loss in adults with overweight or obesity .
- Contradicts
- The claim is too broad if it implies that peptides and nutraceuticals as a class are established, reliable weight-loss interventions. [17][19][20] The evidence base for most nutraceuticals is weak, inconsistent, and typically shows only small effects; major reviews of weight-loss supplements conclude that little proof exists for long-term weight loss, and the benefit varies by product and study quality. The peer-reviewed index papers provided do not include obesity guidelines or RCTs specifically supporting nutraceuticals as a general weight-loss strategy, and several listed guidelines are unrelated to obesity or weight loss. [14][18] The peptide literature also includes many preclinical or mechanistic papers rather than human clinical outcomes, so much of the peptide-for-weight-loss space remains investigational. Reviews of anti-obesity peptides emphasize that many candidates are still at the discovery or preclinical stage .
- Mainstream view
- Mainstream medical practice distinguishes between prescription peptide drugs for obesity, which are evidence-based and guideline-supported in selected patients, and nutraceuticals, which are not considered standard or dependable weight-loss therapy. [13][17][18][19] The consensus view is that GLP-1–based medications can meaningfully reduce body weight in eligible patients, while most nutraceuticals have at best small adjunctive effects and should not be presented as proven standalone weight-loss treatments. For most peptide and nutraceutical products marketed for weight loss outside approved medications, evidence remains insufficient or low quality.
“cutting-edge therapies like peptides and nutraceuticals”
Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Dr. Arthur Elliot Hirshorn is not approved to offer Platelet-rich plasma (PRP) and regenerative medicine within a Chiropractor scope of practice under South Carolina Board of Chiropractic Examiners.
Platelet-rich plasma (PRP) and regenerative medicine
- Supports
- High-quality evidence for platelet-rich plasma (PRP) exists in specific niches of regenerative medicine, mainly musculoskeletal disorders, osteoarthritis, low back pain, and androgenetic alopecia, but not as a universal regenerative cure-all. [23][24][25][26][27] Multiple randomized controlled trials and meta-analyses in knee osteoarthritis show that intra-articular PRP injections can provide statistically and clinically significant improvements in pain and function compared with placebo and sometimes with hyaluronic acid or corticosteroid, particularly over 3–12 months, with effects influenced by platelet concentration and PRP preparation. [22][28] These data underlie technology assessments and guidelines that acknowledge symptomatic benefit for knee OA, even though they stop short of strong recommendations. Systematic reviews of PRP for chronic low back pain and musculoskeletal soft-tissue injuries (e. [21] g. , tendinopathies, rotator cuff pathology) report that many RCTs demonstrate pain reduction and functional gains compared with control injections, with generally low rates of adverse events and a reasonable safety profile. Regenerative medicine-style combinations, such as PRP with stem cell therapies for musculoskeletal injuries, show early pain relief and functional improvements in randomized and controlled studies, suggesting biological plausibility for a regenerative role, although heterogeneity in protocols limits firm conclusions. For androgenetic alopecia, meta-analyses and clinical trials support that locally injected PRP can increase hair density and hair count and improve patient-rated outcomes, and PRP combined with standard treatments such as minoxidil appears more effective than monotherapy. Overall, across these domains, PRP is supported as a safe, minimally invasive biologic that can modify symptoms and, in some contexts, may enhance tissue healing, but the evidence base is condition-specific and does not substantiate broad claims of systemic or generalized regeneration.
- Contradicts
- Despite promising results, evidence for PRP and broader regenerative medicine claims is inconsistent, often modest in magnitude, and frequently limited by small sample sizes, short follow-up, and heterogeneous preparation protocols. For many musculoskeletal indications (e. [21][25] g. , chronic tendinopathy, some post-surgical applications), high-quality RCTs and meta-analyses show either no clinically important difference between PRP and placebo or only marginal benefit that may not clearly exceed minimal clinically important differences, making strong efficacy claims premature. In knee osteoarthritis, although meta-analyses support short- to medium-term symptomatic improvements, guidelines and technology assessments emphasize that current data are insufficient to endorse routine use, and they highlight uncertainties around optimal dosing, activation, leukocyte content, and long-term structural benefit. Some randomized trials in specific populations (such as hemophilic knee arthritis) find no advantage of PRP over placebo in pain or function over long-term follow-up, directly contradicting the notion that PRP is universally effective for joint degeneration. [22][28] In low back pain and other degenerative spinal conditions, systematic reviews classify the evidence as moderate quality at best and call for large, multicenter RCTs, noting that existing positive trials are often single-center with potential bias. [23][24][26][27] For regenerative claims involving true tissue regeneration or disease modification (e. g. , reversing osteoarthritis or disc degeneration, broadly rejuvenating tissues), there is little robust human evidence; most support is either indirect (symptom improvement) or comes from small mechanistic and animal studies, so strong influencer claims of transformative or global regeneration are not well substantiated.
- Mainstream view
- The mainstream medical and scientific position is that platelet-rich plasma is an experimental or adjunctive biologic therapy with condition-specific evidence, not a universally validated regenerative medicine solution. [22][23][24][25][26] For knee osteoarthritis and certain musculoskeletal injuries, professional societies and technology reviews acknowledge that PRP can improve pain and function in some patients and appears safe, but they generally classify it as an option with limited, heterogeneous evidence and do not issue strong, routine-use recommendations; many guidelines describe the evidence as promising yet inconclusive and often state that routine clinical use should be cautious or restricted to selected cases or research settings. [21][27][28] For chronic low back pain and other degenerative spinal or soft-tissue conditions, PRP is viewed as investigational, with moderate-level evidence suggesting benefit but a clear need for more rigorous, standardized, multicenter trials before broad clinical endorsement. In dermatology and hair restoration, PRP is increasingly used for androgenetic alopecia as an adjunct to established therapies, with recognition that RCTs and meta-analyses show benefit on hair density and count, but still with calls for protocol standardization and longer-term safety and efficacy data. Overall, mainstream experts consider PRP a relatively safe, biologically plausible therapy that can provide symptom relief and possibly enhance healing in selected indications, but they reject broad claims of generalized or systemic regenerative effects and stress that most uses remain off-label, research-oriented, and dependent Deterministic PubMed cross-check found no matching indexed studies for these terms (absence of indexed evidence is not evidence against the claim).
“platelet-rich plasma (PRP), regenerative medicine”
Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care)
Manipulation
False Authority
transcript · cited
The practice claims 'functional medicine' can identify the 'root cause' of chronic conditions, a term often used to imply a diagnostic capability that standard medical boards do not grant to non-MD/DO functional practitioners, especially when paired with unproven therapies like peptides for weight loss. Likely motive: To position the clinic as the only solution for complex, undiagnosed symptoms, bypassing standard care pathways.
“we go beyond symptom management, addressing the root cause of your health concerns”
Proprietary Product Funnel
transcript · cited
The clinic promotes 'peptides' (often unapproved or off-label) and 'nutraceuticals' for weight loss, framing them as 'cutting-edge' to bypass insurance and standard FDA-approved weight loss medications. Likely motive: To sell high-cost, non-insured supplements and injectables directly to patients.
“cutting-edge therapies like peptides and nutraceuticals, we support optimal metabolism”
Commerce & grift map
The clinic uses 'root cause' and 'advanced lab testing' to scare patients into believing standard care failed, then sells proprietary lab panels and a Fullscript supplement stack (with hidden markup) to 'fix' the imbalance. The lack of disclosure on the supplement link compounds the grift.
Fullscript
Supplement / productPays providers to recommendHigh confidence
- Dispensing markup
- Affiliate commission
Fullscript pays practitioners a markup or referral fee on every supplement sold through their practitioner store, creating a hidden financial incentive to recommend their products.
Patient program: Patients typically order through a practitioner’s Fullscript online store/dispensary, where the practitioner can choose whether to earn revenue, offer savings, or both, by setting a profit margin up to about 35%. Orders ship directly to patients from Fullscript, and the practitioner’s earnings from those patient orders accrue and are paid out to the practitioner’s business bank account approximately every 30 days.
Doc Bro outbound link (live) · Archived copy →
Vendor provider compensation page (live) · Archived copy →
Vendor research sources
- Top 9 Side Gigs and Passive Income Streams for Physicians (Fullscript blog)Official
- Fullscript Affiliate ProgramOfficial
- Fullscript Referral / Affiliate Program ToolkitOfficial
- Fullscript Referral Toolkit (dispensing supplements, grow your practice)Official
- How to generate passive income with the Fullscript + Practice Better ...
- #171: How I Use Fullscript as a Secondary Income Stream - Health ...
- Unethical that Fullscript provides kickbacks to providers and hides it ...
- Healthcare Partnerships - FullscriptOfficial
- Fullscript: Supplement Management & Lab Testing PlatformOfficial
- Adding practitioners and staff | Video - Fullscript Support CenterOfficial
Supplements pitched
- Fullscript Practitioner Store
“Fulllscript: https://us.fullscript.com/welcome/newlife/store-start”
Labs pitched
- Advanced Lab Testing for Root Cause
“Through advanced lab testing... we help you... uncover the root cause of imbalance”
How the money flows
- In-office dispensing markupUndisclosed Fullscript practitioner store link implies a markup or referral fee on supplement sales. “Fulllscript: https://us.fullscript.com/welcome/newlife/store-start”
“Fulllscript: https://us.fullscript.com/welcome/newlife/store-start”
- Affiliate / promo linkUndisclosed Outbound commerce store links with strong affiliate or practitioner-markup signals, but no clear FTC-style material-connection disclosure on the page.
Store links detected
- FulllscriptHigh likelihood
“Practitioner supplement dispensary”
Sponsors and advertisers
Brands, advertisers, and agencies connected to this content, based on what it promotes and discloses.
- FullscriptBrand
Promoted commerce partner
- Fullscript Practitioner StoreBrand
Named on a surface without a compensation disclosure
- Advanced Lab Testing for Root CauseBrand
Named on a surface without a compensation disclosure
Credentials & scope
Glossary: Chiropractor (“Dr.”)
Stated: DO, Chiropractor
Verified against the federal provider registry: DC, DACNB · Chiropractor · SC license 3781.
The practitioner uses the 'Dr.' title to imply broad medical authority while offering systemic treatments (TRT, peptides, hormone balancing) that typically exceed the scope of non-MD/DO functional practitioners.
Permitted scope vs advertised
South Carolina Board of Chiropractic Examiners · Confidence: high
South Carolina chiropractic practice is limited to spinal analysis and adjustment of the vertebral column and its immediate articulations for restoration and maintenance of health, and related diagnostic and therapeutic procedures generally used in chiropractic, all explicitly without the use of drugs or surgery.[1][5] Chiropractors may perform diagnostic and testing procedures and certain therapeutic modalities, but their licensed practice is confined to chiropractic care and does not include prescribing or administering drugs, performing surgery, or practicing medicine.[1][5]
What this license permits
- Spinal adjustment and manipulation
- Musculoskeletal evaluation and treatment
- Soft-tissue and rehabilitative care
- Headache care within musculoskeletal scope
- Chiropractic spinal analysis focused on nerve transmission (S.C. Code Ann. § 40-9-10(b); Board scope of practice policy (SCLLR Board of Chiropractic Examiners Scope of Practice))
- Physical examination and chiropractic diagnostic procedures (S.C. Code Ann. § 40-9-10(c); S.C. Code Regs. § 25-5; Board scope of practice policy)
- Use and ordering of x‑ray in chiropractic practice (S.C. Code Ann. § 40-9-10(c); Board scope of practice policy)
19 of 19 advertised activities fall outside permitted scope.
| Advertised | Verdict |
|---|---|
| Listed service Testosterone and hormone replacement therapy (HRT/TRT) Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)-(2) South Carolina chiropractic practice is explicitly defined as being performed "without the use of drugs or surgery," and testosterone/HRT are drug-based medical therapies outside chiropractic scope.[5][1] | Outside scope |
| Listed service Psoriasis Treatment Rule: S.C. Code § 40-9-10(a)-(c); S.C. Code Regs. § 25-5(1)-(2) The statute limits chiropractors to spinal analysis, adjustment, x‑ray, and procedures generally used in chiropractic, not direct treatment of systemic dermatologic diseases like psoriasis.[1][5] | Outside scope |
| Listed service Autoimmune Disease Rule: S.C. Code § 40-9-10(a)-(b); S.C. Code Regs. § 25-5(1)-(2) The chiropractic scope focuses on spinal and related neuromusculoskeletal conditions and does not affirmatively authorize diagnosing or managing systemic autoimmune diseases as medical conditions.[1][5] | Outside scope |
| Listed service Chronic Fatigue Rule: S.C. Code § 40-9-10(a)-(c); S.C. Code Regs. § 25-5(2)(c) While chiropractors may evaluate patients, the statute does not affirmatively authorize diagnosing or treating systemic syndromes such as chronic fatigue syndrome beyond chiropractic neuromusculoskeletal care.[1][5] | Outside scope |
| Listed service IBS & Gastrointestinal Issues Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)-(2) The chiropractic practice act does not affirmatively permit diagnosing or treating gastrointestinal diseases; scope is limited to spinal analysis, adjustment, and related chiropractic procedures without practicing medicine.[1][5] | Outside scope |
| Listed service Infertility Rule: S.C. Code § 40-9-10(a)-(b); S.C. Code Regs. § 25-5 Infertility diagnosis and treatment are medical/gynecologic services, and the chiropractic statute does not affirmatively authorize chiropractors to diagnose or treat reproductive endocrinology or fertility conditions.[1][5] | Outside scope |
| Listed service Thyroid Disease Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1)-(2) Thyroid disease is an endocrine/systemic condition, and the South Carolina chiropractic scope does not affirmatively authorize endocrinologic diagnosis or management.[1][5] | Outside scope |
| Listed service Hormone Replacement Therapy (HRT) Rule: S.C. Code § 40-9-10(b) Hormone replacement therapy involves prescribing and managing drugs, which is expressly excluded because chiropractic practice must be without the use of drugs or surgery.[5][1] | Outside scope |
| Listed service Testosterone Replacement Therapy (TRT) Rule: S.C. Code § 40-9-10(b) TRT is a prescription drug therapy and South Carolina law restricts chiropractors to practice "without the use of drugs," so prescribing or managing TRT exceeds their authorized scope.[5][1] | Outside scope |
| Prescribing testosterone replacement therapy (TRT) and peptide therapy for weight loss, which are medical treatments typically restricted to MD/DO physicians. Rule: S.C. Code § 40-9-10(b); S.C. Code Regs. § 25-5(1) South Carolina chiropractors are limited to chiropractic procedures and may not use or prescribe drugs such as testosterone or peptides, which constitute medical/pharmacologic treatment.[1][5] | Outside scope |
| Hormone replacement therapy (TRT) for men and women Rule: S.C. Code § 40-9-10(b) Providing TRT for men and women is drug-based hormone therapy, directly barred by the statutory requirement that chiropractic practice be conducted without the use of drugs.[5][1] | Outside scope |
| Listed service Laser vaginal rejuvenation Rule: S.C. Code § 40-9-10(b); S.C. Laser vaginal rejuvenation is a gynecologic/esthetic surgical or medical procedure and is not among the spinal and neuromusculoskeletal chiropractic procedures authorized by statute or regulations.[1][5] | Outside scope |
| Listed service Peptides and nutraceuticals for weight loss Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Platelet-rich plasma (PRP) and regenerative medicine Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Advanced lab testing for root cause diagnosis Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Listed service Hormone balancing for chronic illness prevention Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care) | Outside scope |
| Diagnosing and treating systemic hormone imbalances and chronic illness via 'root cause' functional medicine, which exceeds the scope of non-MD/DO practitioners (e.g., DC, ND). Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care) | Outside scope |
| Peptide therapy for weight loss Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
| Advanced lab testing for 'root cause' diagnosis Rule: South Carolina Chiropractic Practice Act (scope limited to musculoskeletal/spine care) Not listed among permitted DC scope activities under the governing practice act. | Outside scope |
Sources: South Carolina Code Title 40, Chapter 9 – Chiropractic Practice Act (official), S.C. Code Regs. § 25-5 – Professional Practices (South Carolina Board of Chiropractic Examiners) (official), South Carolina Board of Chiropractic Examiners – Laws/Policies Page (official), FCLB summary of South Carolina chiropractic scope
Scope comparison mirror
Side-by-side view of the archived marketing homepage and what a Chiropractor scope permits near Circle Greenville, SC. Open the mirror for the full comparison: archive on the left, permitted scope and licensed-care paths on the right.
Mirror generated 2026-07-16 13:28 UTC. The archive pane loads styles and images from the intake snapshot.
10 licensed-care paths linked for out-of-scope claims.
Validated associated properties
Surfaces tied to this Doc Bro by domain, branding, or funnel routing. Third-party platforms are labeled as routes, not as owned properties.
Analyzed
- OwnedOfficial site (renewingfunction.com)
Tip the jar
Report useful? Optional tips help keep scans, archives, and literature cross-checks running. They never change conclusions.
Submission xgLHK4SA6kEtnA07nwkVa
Fight disinformation
Log a public thread where Dr. Arthur Elliot Hirshorn is spreading nonsense, get a copy-paste reply with this report link.
Reply snippets
Before you buy the protocol: Dr. Trust Me Bro fact-checked Dr. Arthur Elliot Hirshorn's claims with peer-reviewed sources, https://drtrustmebro.com/analyze/xgLHK4SA6kEtnA07nwkVa. White-coat charisma isn't evidence.
Full DTMB scan on Dr. Arthur Elliot Hirshorn: https://drtrustmebro.com/analyze/xgLHK4SA6kEtnA07nwkVa
Drop these in YouTube comments, Reddit threads, and forums, link back to this scan, not vibes.
Recent mentions (this doc)
- YouTube
Greenville SC Thyroid Clinic Explains The Right Way to Test
One of Dr. Elliott Hirshorn's own recent posts. The comment thread is where this pitch spreads, reply there with the report link.
- YouTube
Understanding Thyroid Health with Dr. Elliot Hirshorn
One of Dr. Elliott Hirshorn's own recent posts. The comment thread is where this pitch spreads, reply there with the report link.
- YouTube
Greenville SC Thyroid Clinic Explains The Right Way to Test
One of Arthur Elliot Hirshorn's own recent posts. The comment thread is where this pitch spreads, reply there with the report link.
- YouTube
Understanding Thyroid Health with Dr. Elliot Hirshorn
One of Arthur Elliot Hirshorn's own recent posts. The comment thread is where this pitch spreads, reply there with the report link.
Nudge the Doc Bro
We could not find a public contact email for Dr. Arthur Elliot Hirshorn. Reach them through their own site and ask them to review this dossier and correct anything we got wrong.
Know someone who can help?
If you think someone has firsthand information about Dr. Arthur Elliot Hirshorn, send them an encouraging note. We email a short, respectful message with this report and clear instructions on how to write in, on the record or anonymously.
Whambulance
Challenge this scan or Wall of Fame entry for Dr. Arthur Elliot Hirshorn. Public log, not legal arbitration.
Public challenge log
No posted Wall of Fame challenges linked yet.
Challenges are public on the Wall of Fame card. DTMB does not remove entries for hurt feelings, primary sources or copy corrections only.
File a challenge
Include in your email:
- Doc Bro ID: bzRCn1joQUSFyID0fnfbA
- Wall entry: /influencer/bzRCn1joQUSFyID0fnfbA
- Analysis ID: xgLHK4SA6kEtnA07nwkVa
- Source: https://renewingfunction.com/
- Why this entry or scan should change
- Supporting links (one per line)
- Your business email (for verified disputes)
Verified challenges are posted publicly on the report. Public log, not legal arbitration.
Citations
Peer-reviewed and index sources cited in this report.
- [1] The Pre-Testosterone Therapy Checklist.
- [2] Evolution of Guidelines for Testosterone Replacement Therapy
- [3] Efficacy and Safety of Testosterone Therapy Based on Guideline Recommendations; Re: Clinical Practice Guideline by the American College of Physicians
- [4] Approaches to male hypogonadism in primary care
- [5] Controversies in testosterone replacement therapy: testosterone and cardiovascular disease
- [6] Guidelines for testosterone therapy for men: how to avoid a mad (t)ea party by getting personal.
- [7] Randomized placebo-controlled trial of testosterone replacement in ...
- [8] The benefits and risks of testosterone replacement therapy: a review
- [9] Laser therapy for genitourinary syndrome of menopause: systematic review and meta-analysis of randomized controlled trial
- [10] Efficacy and Safety of Laser Therapy for the Treatment of Genitourinary Syndrome of Menopause: A Protocol for Systematic Review and Meta-Analysis of Clinical Trials
- [11] Efficacy of a Diode Vaginal Laser in the Treatment of the Genitourinary Syndrome of Menopause
- [12] Comparison of Severity of Genitourinary Syndrome of Menopause Symptoms After Carbon Dioxide Laser vs Vaginal Estrogen Therapy
- [13] Guideline-Driven Management of Hypertension: An Evidence-Based Update.
- [14] ASPEN-FELANPE Clinical Guidelines.
- [15] ESPEN guideline: Clinical nutrition in inflammatory bowel disease.
- [16] When Is Parenteral Nutrition Appropriate?
- [17] Peptides Evaluated In Silico, In Vitro, and In Vivo as Therapeutic Tools for Obesity: A Systematic Review
- [18] Are peptide conjugates the golden therapy against obesity?
- [19] Research and prospect of peptides for use in obesity treatment (Review).
- [20] Peptides and Peptidomimetics as Potential Antiobesity Agents: Overview of Current Status
- [21] Platelet-rich therapies for musculoskeletal soft tissue injuries.
- [22] A Double-Blinded Placebo Randomized Controlled Trial Evaluating Short-term Efficacy of Platelet-Rich Plasma in Reducing Postoperative Pain After Arthroscopic Rotator Cuff Repair
- [23] Platelet-rich plasma for muscle injuries: A systematic review of the basic science literature
- [24] Platelet-rich plasma in the management of chronic low back pain: a critical review
- [25] Utilization of Platelet-Rich Plasma for Musculoskeletal Injuries
- [26] Real-world evidence to assess the effectiveness of platelet-rich plasma in the treatment of knee degenerative pathology: a prospective observational study
- [27] Use of Platelet-Rich Plasma for the Improvement of Pain and Function in Rotator Cuff Tears: A Systematic Review and Meta-analysis With Bias Assessment
- [28] No Benefit to Platelet-rich Plasma Over Placebo Injections in Terms of Pain or Function in Patients with Hemophilic Knee Arthritis: A Randomized Trial
- [29] Clinical Decision Making—A Functional Medicine Perspective
- [30] Addressing the Drivers of Medical Test Overuse and Cascades: User-Centered Design to Improve Patient-Doctor Communication.
- [31] Overuse of diagnostic testing in healthcare: a systematic review
- [32] Why clinicians overtest: development of a thematic framework